12:00 AM
May 07, 2012
 |  BC Week In Review  |  Company News  |  Deals

Hanmi Pharmaceutical, SK Biopharmaceuticals deal

SK Biopharmaceuticals granted Hanmi rights to market diazepam nasal spray in China and Korea. SK will receive an undisclosed upfront payment, and will be...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >